<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
ABBOTT LABORATORIES' 1998 FIRST QUARTER FORM 10-Q AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED> 
<MULTIPLIER> 1,000
       
                                                                                            
<PERIOD-TYPE>                   3-MOS                   6-MOS                   9-MOS                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996             DEC-31-1996             DEC-31-1996             DEC-31-1995
<PERIOD-START>                             JAN-01-1996             JAN-01-1996             JAN-01-1996             JAN-01-1995
<PERIOD-END>                               MAR-31-1996             JUN-30-1996             SEP-30-1996             DEC-31-1995
<CASH>                                          87,922                 111,482                 139,896                 281,197
<SECURITIES>                                    44,035                  66,189                  39,274                  34,500
<RECEIVABLES>                                1,718,488               1,791,459               1,700,153               1,721,028
<ALLOWANCES>                                   156,167                 147,550                 150,415                 157,990
<INVENTORY>                                  1,156,918               1,195,242               1,224,705               1,110,941
<CURRENT-ASSETS>                             4,113,266               4,326,405               4,273,851               4,226,711
<PP&E>                                       7,895,249               8,044,533               8,242,116               7,762,442
<DEPRECIATION>                               3,621,131               3,709,198               3,839,638               3,512,904
<TOTAL-ASSETS>                               9,312,020              10,553,874              10,669,342               9,412,580
<CURRENT-LIABILITIES>                        3,491,495               4,526,824               4,287,888               3,790,314
<BONDS>                                        433,724                 433,437                 682,166                 435,198
<PREFERRED-MANDATORY>                                0                       0                       0                       0
<PREFERRED>                                          0                       0                       0                       0
<COMMON>                                       608,933                 628,216                 659,274                 581,562
<OTHER-SE>                                   3,956,734               4,012,280               4,054,696               3,815,285
<TOTAL-LIABILITY-AND-EQUITY>                 9,312,020              10,553,874              10,669,342               9,412,580
<SALES>                                      2,672,177               5,371,417               8,017,611              10,012,194
<TOTAL-REVENUES>                             2,672,177               5,371,417               8,017,611              10,012,194
<CGS>                                        1,156,217               2,300,164               3,477,411               4,325,805
<TOTAL-COSTS>                                1,156,217               2,300,164               3,477,411               4,325,805
<OTHER-EXPENSES>                               268,616 <F1>            573,462 <F1>            852,432 <F1>          1,072,745 <F1>

<LOSS-PROVISION>                                13,838                   4,465                  23,999                  32,462
<INTEREST-EXPENSE>                              17,607                  39,835                  68,030                  69,532
<INCOME-PRETAX>                                681,005               1,348,272               1,945,275               2,395,319
<INCOME-TAX>                                   200,896                 397,740                 573,856                 706,619
<INCOME-CONTINUING>                            480,109                 950,532               1,371,419               1,688,700
<DISCONTINUED>                                       0                       0                       0                       0
<EXTRAORDINARY>                                      0                       0                       0                       0
<CHANGES>                                            0                       0                       0                       0
<NET-INCOME>                                   480,109                 950,532               1,371,419               1,688,700
<EPS-PRIMARY>                                     0.61                    1.21                    1.75                    2.12
<EPS-DILUTED>                                     0.60                    1.20                    1.73                    2.10
<F30>
<FN>
<F1>Other expenses consist of research and development expenses
</FN>